02.05.2024 08:11:34 - dpa-AFX: *AZN : CALQUENCE COMBINATION REGIMEN SHOWS PFS IMPROVEMENT IN FIRST-LINE MANTLE CELL LYMPHOMA IN PHASE III TRIAL

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
ASTRAZENECA PLC DL-,25 886455 Frankfurt 144,300 24.05.24 15:17:28 -1,650 -1,13% 145,000 147,000 145,050 145,950

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH